DR REDDY LABORATORIES MALAYSIA SDN

Business Type: Trading and Distribution (This entity acts as the Malaysian subsidiary for the global pharmaceutical group, focusing on the registration, marketing, and distribution of pharmaceutical products rather than primary manufacturing.)

Company Profile:

Dr. Reddy Laboratories Malaysia Sdn Bhd is a subsidiary of Dr. Reddy Laboratories Ltd, a global pharmaceutical company headquartered in India. The Malaysian entity serves as the commercial hub for the region, dedicated to providing high-quality, affordable medicines to the Malaysian market. Its core operations include the strategic management of product registrations with local health authorities, supply chain coordination, and the distribution of a diverse portfolio of generic drugs, biosimilars, and active pharmaceutical ingredients. By leveraging the parent company's extensive research and development capabilities, Dr. Reddy Laboratories Malaysia plays a vital role in enhancing healthcare accessibility across the country.

DR REDDY LABORATORIES MALAYSIA SDN BHD PRODUCT PORTFOLIO

Oncology Products

Docetaxel Injection

Paclitaxel Injection

Gemcitabine Injection

Capecitabine Tablets

Irinotecan Hydrochloride Injection

Gastroenterology Products

Omeprazole Capsules

Esomeprazole Tablets

Pantoprazole Injection

Cardiovascular Products

Amlodipine Besylate Tablets

Atorvastatin Calcium Tablets

Clopidogrel Bisulfate Tablets

Telmisartan Tablets

Pain Management and Anti-inflammatory Products

Diclofenac Sodium Injection

Ibuprofen Tablets

Naproxen Tablets

Anti-infective Products

Ciprofloxacin Tablets

Levofloxacin Tablets

Other Therapeutic Areas

Fluconazole Capsules

Montelukast Sodium Tablets

Donepezil Hydrochloride Tablets

Note: The availability of these products is subject to local regulatory approvals and market distribution updates in Malaysia.